Financial

The Cigna Group reported a profit of $1.7 billion for the second quarter of 2026, a year-over-year increase of more than 8%, according to a July 30 earnings report. Total revenue reached $71.7 billion for the quarter, up about 7%…

Humana reported a $694 million profit for the second quarter, up more than 27% year over year, according to its July 29 earnings report. Revenue reached $40.8 billion, a 26% increase from the same period in 2025, driven by Medicare…

Deferred elective surgery was a through-line of second-quarter earnings calls at four of the country’s largest for-profit hospital operators. But their executives do not agree on what is driving the slowdown, or whether it represents lost demand at all. Nashville,…

Centene brought in a $1.1 billion profit for the second quarter of 2026, up from a $253 million loss at the same time last year, according to the company’s July 28 earnings report. Total revenue approached $53.6 billion for the…

More data is pointing to concerns of skyrocketing healthcare costs in the upcoming years. Steeper medical utilization is one cause for concern, according to several sources. Meanwhile, HR 1 is radically reshaping Medicaid, and the expiration of ACA enhanced subsidies…

Molina Healthcare reported $60 million in net income for the second quarter of 2026, a 76% year-over-year drop from $255 million. The insurer attributed the decline mainly to lower premium revenue and a higher medical loss ratio. Total revenue for…

UnitedHealth Group posted nearly $5.5 billion in profit for the second quarter of 2026, up sharply from the same period last year. The company released second-quarter earnings July 16, raising its full-year outlook to a range of $18.45 to $18.95…

Elevance Health posted nearly $1.5 billion in profit during the second quarter of 2026, down 16% compared to last year. The company raised full-year guidance for diluted and adjusted diluted earnings per share to be at least $20.10 and $27,…

The HHS Office of Inspector General reported a $5.56 billion in savings and recoveries from Oct. 1, 2025, through March 31, 2026. OIG released its semiannual report in July. The division focuses on fraud, waste and abuse in government healthcare…

CVS Health CEO David Joyner is skeptical as to whether the evidence backs GLP-1 investment right now. “Everybody intuitively believes these medications create long-term health benefits, but the evidence hasn’t yet demonstrated that paying today’s prices generates enough downstream savings,”…